Seelos Therapeutics, Inc. (SEELQ) — Financial Flexibility Index
Seelos Therapeutics, Inc. (SEELQ) has a Financial Flexibility Index of -0.03x as of June 2024. Free cash flow of $-972.00K (operating CF $-972.00K minus capex $0.00) represents 0% of total liabilities ($30.51 Million). Check tangible equity quality of Seelos Therapeutics, Inc. to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seelos Therapeutics, Inc. Financial Flexibility Index (2020–2023)
Historical Financial Flexibility Index trend for Seelos Therapeutics, Inc. across 4 annual periods. For the full cash flow conversion analysis, see SEELQ cash generation efficiency.
Annual Financial Flexibility Index for Seelos Therapeutics, Inc. (2020–2023)
Year-by-year free cash flow to debt coverage for Seelos Therapeutics, Inc.. Explore Seelos Therapeutics, Inc. (SEELQ) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-23.91 Million | $-23.91 Million | $38.93 Million | ▲ +66.7% |
| 2022 | -1.85x | $-61.60 Million | $-61.60 Million | $33.36 Million | ▲ +1.3% |
| 2021 | -1.87x | $-48.99 Million | $-48.99 Million | $26.18 Million | ▼ -33.5% |
| 2020 | -1.40x | $-20.91 Million | $-20.91 Million | $14.92 Million | — |